Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AVINZA Control of Chronic Pain, Effectiveness and Safety Study (ACCESS 2008) A Multi-Center Study to Evaluate the Effectiveness and Tolerability of AVINZA for Chronic Moderate-Severe Pain: A Focus on Risk Minimization Assessment, Intervention and Outcomes

NCT00640042 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00640042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AVINZA Control of Chronic Pain, Effectiveness and Safety Study (ACCESS 2008) A Multi-Center Study to Evaluate the Effectiveness and Tolerability of AVINZA for Chronic Moderate-Severe Pain: A Focus on Risk Minimization Assessment, Intervention and Outcomes
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2008
Enrollment
1,570 (actual)
Sites
384

Conditions

As the registry lists them; a condition with its own page is linked.

pain